Moreover, endothelial YAP/TAZ knockdown or MnCl2 treatment delayed atherogenesis, indicating that YAP/TAZ could become a potential therapeutic target against atherosclerosis [42]. This evidence concerns the gene YAP1 and atherosclerosis.